Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-06

Clinical Trial Update: Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) [NA]

View source ↗

Summary

A clinical trial evaluating internet-delivered management of chemotherapy-induced peripheral neuropathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy | NA | Status: WITHDRAWN